Rapamycin reduces rejection in heart transplant recipients

被引：11

作者：

Radovancevic, B ^{[1
]}

El-Sabrout, R ^{[1
]}

Thomas, C ^{[1
]}

Radovancevic, R ^{[1
]}

Frazier, OH ^{[1
]}

Van Buren, C ^{[1
]}

机构：

[1] Texas Heart Inst, Houston, TX 77030 USA

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 7-8期

关键词：

D O I：

10.1016/S0041-1345(01)02370-3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

收藏

页码：3221 / 3222

页数：2

相关论文

共 3 条

[1] Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression [J].

Hong, JC ;

Kahan, BD .

TRANSPLANTATION, 1999, 68 (05) :701-704

[2] Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study [J].

Kahan, BD .

LANCET, 2000, 356 (9225) :194-202

[3] A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts [J].

MacDonald, AS .

TRANSPLANTATION, 2001, 71 (02) :271-280